| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/14/2007 | EP1761635A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 03/14/2007 | EP1761560A1 Peptide-based compounds |
| 03/14/2007 | EP1761559A2 Fc-INTERFERON-BETA FUSION PROTEINS |
| 03/14/2007 | EP1761558A1 Optimizing expression of active botulinum toxin type e |
| 03/14/2007 | EP1761557A1 Novel gene products from bacillus licheniformis forming or decomposing polyamino acids and improved biotechnological production methods based thereon |
| 03/14/2007 | EP1761556A1 Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein |
| 03/14/2007 | EP1761555A1 Method and device for detecting feline immunodeficiency virus |
| 03/14/2007 | EP1761553A2 Tumor-associated peptides that bind to mhc-molecules |
| 03/14/2007 | EP1761552A1 Process for the purification of il-18 binding protein |
| 03/14/2007 | EP1670916A4 Banana resistance genes and uses thereof |
| 03/14/2007 | EP1664288A4 Mylks as modifiers of branching morphogenesis and methods of use |
| 03/14/2007 | EP1513878B1 Compositions and methods for apo-b48 and apo-b100 assay |
| 03/14/2007 | EP1504098B1 A method for in vitro molecular evolution of protein function |
| 03/14/2007 | EP1497417B1 Epha2 antigen t epitopes |
| 03/14/2007 | EP1490491B1 Use of the protein maba (fabg1) of i mycobacterium tuberculosis /i for designing and screening antibiotics |
| 03/14/2007 | EP1343897B1 Purified active hcv ns2/3 protease |
| 03/14/2007 | EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 03/14/2007 | EP1325956B1 Plant lesion formation suppressing gene, spl7 and use theriof |
| 03/14/2007 | EP1305434B1 A human disintegrin protein |
| 03/14/2007 | EP1229118B1 Plant photoperiod sensitivity gene and use of the same |
| 03/14/2007 | EP1226169B1 Molecular structure of rhd negative locus |
| 03/14/2007 | EP1224302B1 Modified viral surface proteins which bind to cells of tumor vasculature |
| 03/14/2007 | EP1196197B1 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 03/14/2007 | EP1054893B1 Synthetic polymers and methods, kits or compositions for modulating the solubility of same |
| 03/14/2007 | EP0944648B1 Glp-1 derivatives |
| 03/14/2007 | EP0912610B1 A novel galanin receptor |
| 03/14/2007 | EP0698089B1 Nucleic acid encoding amp-activated protein kinase |
| 03/14/2007 | CN1930476A Chemokine CCL18 as a biomarker |
| 03/14/2007 | CN1930461A Methods for diagnosis and pronosis of cancers of epithelial origin |
| 03/14/2007 | CN1930301A Methods for identifying proteins with starch phosphorylating enzymatic activity |
| 03/14/2007 | CN1930299A Nitrile hydratase of rhodococcus |
| 03/14/2007 | CN1930293A Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 03/14/2007 | CN1930292A Proteins imparting boron-tolerance and genes thereof |
| 03/14/2007 | CN1930291A Modified promoter |
| 03/14/2007 | CN1930285A Polypeptides of alicyclibacillus |
| 03/14/2007 | CN1930284A Infectious bursal disease virus antigenic isolates and vaccines |
| 03/14/2007 | CN1930188A Estrogen receptors and methods of use |
| 03/14/2007 | CN1930187A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 03/14/2007 | CN1930186A Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 03/14/2007 | CN1930185A Canine vaccine for protection against ehrlichiosis |
| 03/14/2007 | CN1930184A Novel TAT complexes, and vaccines comprising them |
| 03/14/2007 | CN1929867A Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines |
| 03/14/2007 | CN1929857A N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof |
| 03/14/2007 | CN1928089A Total genome of HIV virus |
| 03/14/2007 | CN1928086A Gene sequence of sparus latus houttuyn actin |
| 03/14/2007 | CN1928085A Gene sequence of penaeus monodon cell periodic protein B |
| 03/14/2007 | CN1928084A Nucleotide and amino acid sequence of gene of penaeus monodon heat shock protein 90 |
| 03/14/2007 | CN1927883A 新的细胞因子zalpha11配体 New cytokine zalpha11 Ligand |
| 03/14/2007 | CN1927882A Sugar conjugated protein with resistant action of human acquired immunity system synthesis disease virus activity |
| 03/14/2007 | CN1927881A Polypeptide, preparation method thereof, pharmaceutical composition and vaccine containing the same and application thereof |
| 03/14/2007 | CN1304581C Compositions and methods for treating neurodegenerative diseases |
| 03/14/2007 | CN1304580C Surface glucoprotein gp160 of recombination expression human acquired immunity defact virus 1 |
| 03/14/2007 | CN1304578C Ecdysone receptor-based inducible gene expression system |
| 03/14/2007 | CN1304574C Recombination human erythropoietin gene suitable for pronucleus expression system and its expression carrier |
| 03/14/2007 | CN1304573C NDRG2 and NDRG4 protein and their use for diagnosing and suppressing tumour |
| 03/14/2007 | CN1304568C Novel human complement C1r-like serine proteinase analogue, and its encoding sequence and use |
| 03/14/2007 | CN1304559C Oncolytic microorganism expressing heat shock protein and its application |
| 03/14/2007 | CN1304426C Signal system and elements used therein |
| 03/14/2007 | CN1304424C Compounds with growth hormone releasing properties |
| 03/14/2007 | CN1304423C Urotensin-II agonists and antagonists |
| 03/14/2007 | CN1304422C Non-amidated omega-conotoxin VIIA and its prepn process and application |
| 03/14/2007 | CN1304421C Peptides having affinity for the GP 120 viral protein and use thereof |
| 03/14/2007 | CN1304410C Tumor necrosis factor-Gamma |
| 03/14/2007 | CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 03/13/2007 | US7189906 Desirable traits include greater yield, better stalks, better roots, resistance to insecticides, herbicides, pests, and disease, tolerance to heat and drought, reduced time to crop maturity, better agronomic quality, higher nutritional value, and uniformity in germination times |
| 03/13/2007 | US7189904 Plants and seeds of corn variety I285287 |
| 03/13/2007 | US7189895 Increasing flavonoid production in soy bean plants; food processing; nutrients; beverages |
| 03/13/2007 | US7189893 Trangenic plants coding nucleotide sequences which are associated with abiotic stress responses and abiotic stress tolerance in plants; genetic engineering and drought, freeze and heat resistance |
| 03/13/2007 | US7189892 Nucleic acids encoding phloem small RNA-binding proteins and transgenic plants comprising them |
| 03/13/2007 | US7189891 Isolated ferric reductase defective polypeptides and uses thereof |
| 03/13/2007 | US7189890 Comprises DNA sequences associated with propagation, culturing and cloning of rice, maize, barley and/or wheat |
| 03/13/2007 | US7189889 Adjusting seed phenotype in plants; obtain cells, transform with vector, recover transformed cells, propagate, mointor phenotype of aleurone cells |
| 03/13/2007 | US7189840 Oncosuppressive gene |
| 03/13/2007 | US7189839 An isolated polynucleotide that encodes a polypeptide comprising an amino acid sequence that represents the extracellular domain, also called a cytokine-binding domain, of a new human soluble class II cytokine receptor designated Zcytor16; antiarthritic and -inflammatory agents; autoimmune diseases |
| 03/13/2007 | US7189838 PRO9834 nucleic acids |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189835 Which allows use of Pichia as host cells for producing large amounts of recombinant proteins |
| 03/13/2007 | US7189833 Prostate cancer gene |
| 03/13/2007 | US7189832 Gamma subunit of cytokine responsive IκB-alpha kinase complex and methods of using same |
| 03/13/2007 | US7189830 Anti-KSA/IL-2 fusion proteins with reduced immunogenicity |
| 03/13/2007 | US7189829 Thrombin-activatable fibrinolysis inhibitors (TAFI) enzyme molecules; inhibit the breakdown of blood clots, for use in treatment of blood disorders wherein clotting needs to be regulated or promoted, such as hemophilia or von Willebrand's disease |
| 03/13/2007 | US7189828 use of glycopeptides containing sulfated tyrosines and sialyated, fucosylated N-acetyllactosamino glycans; for treating inflammation, ischemia-reperfusion injury, rheumatoid arthritis, atherosclerosis, leukocyte-mediated lung injury, restenosis, and thrombosis |
| 03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
| 03/13/2007 | US7189823 Monoclonal antibody useful in the diagnosis of proliferative disorders of the colon such as colon cancer; ILLFDYFNR is a colon cancer antigen sequence |
| 03/13/2007 | US7189819 Humanized antibodies that recognize beta amyloid peptide |
| 03/13/2007 | US7189818 Transcriptional regulator |
| 03/13/2007 | US7189817 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2007 | US7189816 Antibody having a binding structure comprising specified complementarity determining region (CDR) sequences for a target tumor antigen on human gastrointestinal epithelial tumour cells; colon cancer diagnosis or immunotherapy |
| 03/13/2007 | US7189813 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 03/13/2007 | US7189812 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 03/13/2007 | US7189811 Process for solubilization of recombinant proteins expressed as inclusion body |
| 03/13/2007 | US7189810 Polypeptides, use thereof and process for producing the same |
| 03/13/2007 | US7189809 Genetic engineered ioslated polynucleotide; anticholesterol agents, Alzheimer's disease, antilipemic agents |
| 03/13/2007 | US7189808 Use of carboxy-terminal fragment of Ki-67 protein or of an active part, fragment or homologue thereof as compound that can be used for intracellular transfer and for introduction into and release by cells; antiinflammatory, anticancer agents |
| 03/13/2007 | US7189807 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 03/13/2007 | US7189806 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 03/13/2007 | US7189805 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2007 | US7189804 PRO1335 polypeptides |
| 03/13/2007 | US7189803 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/13/2007 | US7189801 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |